Tesaglitazar: GLAD all over in diabetes, insulin resistance

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1500, 2005-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myocardial Insulin Resistance and Cardiac Complications of Diabetes

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 219-226

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Effects of Dietary Anthocyanins on Diabetes and Insulin Resistance

Current Drug Targets, Vol. 18, Iss. 6, 2017-03 ,pp. : 629-640

Bentham Science Publishers

Access to resources Recommend Favorite

The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes

By Eldar-Finkelman Hagit Kaidanovich Oksana

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 555-561

Informa Healthcare

Access to resources Recommend Favorite

Peroxynitrite-Driven Mechanisms in Diabetes and Insulin Resistance - the Latest Advances

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 280-290

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes

Current Drug Targets, Vol. 7, Iss. 11, 2006-01 ,pp. : 1435-1441

Bentham Science Publishers

Access to resources Recommend Favorite